Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever

被引:132
作者
Shi, Yuyan [1 ]
机构
[1] Univ Calif San Diego, Dept Family Med & Publ Hlth, MC 0607, San Diego, CA 92103 USA
关键词
Medical marijuana; Law; Marijuana; Opioid; Overdose; Hospitalization; DRUG-MONITORING PROGRAMS; DEATH RATES; PUBLIC-HEALTH; UNITED-STATES; CANNABIS USE; LAWS REDUCE; OVERDOSE; REDUCTIONS; PREVALENCE; MORTALITY;
D O I
10.1016/j.drugalcdep.2017.01.006
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objectives: Twenty-eight states in the U.S have legalized medical marijuana, yet its impacts on severe health consequences such as hospitalizations remain unknown. Meanwhile, the prevalence of opioid pain reliever (OPR) use and outcomes has increased dramatically. Recent studies suggested unintended impacts of legalizing medical marijuana on OPR, but the evidence is still limited. This study examined the associations between state medical marijuana policies and hospitalizations related to marijuana and OPR. Methods: State-level annual administrative records of hospital discharges during 1997-2014 were obtained from the State Inpatient Databases (SID). The outcome variables were rates of hospitalizations involving marijuana dependence or abuse, opioid dependence or abuse, and OPR overdose in 1000 discharges. Linear time-series regressions were used to assess the associations of implementing medical marijuana policies to hospitalizations, controlling for other marijuana- and OPR-related policies, socioeconomic factors, and state and year fixed effects. Results: Hospitalizations related to marijuana and OPR increased sharply by 300% on average in all states. Medical marijuana legalization was associated with 23% (p = 0.008) and 13% (p = 0.025) reductions in hospitalizations related to opioid dependence or abuse and OPR overdose, respectively; lagged effects were observed after policy implementation. The operation of medical marijuana dispensaries had no independent impacts on OPR-related hospitalizations. Medical marijuana polices had no associations with marijuana-related hospitalizations. Conclusion: Medical marijuana policies were significantly associated with reduced OPR-related hospitalizations but had no associations with marijuana-related hospitalizations. Given the epidemic of problematic use of OPR, future investigation is needed to explore the causal pathways of these findings. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:144 / 150
页数:7
相关论文
共 37 条
[21]  
LYAPUSTINA T, 2016, Patent No. 159190
[22]   Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials [J].
Lynch, M. E. ;
Ware, Mark A. .
JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2015, 10 (02) :293-301
[23]   The Effect of Medical Marijuana Laws on Crime: Evidence from State Panel Data, 1990-2006 [J].
Morris, Robert G. ;
TenEyck, Michael ;
Barnes, J. C. ;
Kovandzic, Tomislav V. .
PLOS ONE, 2014, 9 (03)
[24]  
NAMSDL, 2015, PDMP DAT OP
[25]  
( NIDA) National Institute of Drug Abuse, 2015, DRUGFACTS NAT TRENDS
[26]   Assessing the Effects of Medical Marijuana Laws on Marijuana Use: The Devil is in the Details [J].
Pacula, Rosalie L. ;
Powell, David ;
Heaton, Paul ;
Sevigny, Eric L. .
JOURNAL OF POLICY ANALYSIS AND MANAGEMENT, 2015, 34 (01) :7-31
[27]   The incremental inpatient costs associated with marijuana comorbidity [J].
Pacula, Rosalie Liccardo ;
Ringel, Jeanne ;
Dobkin, Carlos ;
Truong, Khoa .
DRUG AND ALCOHOL DEPENDENCE, 2008, 92 (1-3) :248-257
[28]  
Pacula Rosalie Liccardo, 2014, J Drug Policy Anal, V7, P1
[29]   Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates [J].
Patrick, Stephen W. ;
Fry, Carrie E. ;
Jones, Timothy F. ;
Buntin, Melinda B. .
HEALTH AFFAIRS, 2016, 35 (07) :1324-1332
[30]   Prescription Drug Monitoring Programs and Death Rates from Drug Overdose [J].
Paulozzi, Leonard J. ;
Kilbourne, Edwin M. ;
Desai, Hema A. .
PAIN MEDICINE, 2011, 12 (05) :747-754